Kidswell Bio Corporation (4584.T)
JPY 126.0
(-0.79%)
JPY 126.0
(-0.79%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.03 Billion JPY | -31.87% |
| 2022 | 1.52 Billion JPY | 49.74% |
| 2021 | 1.01 Billion JPY | 16.18% |
| 2020 | 876.97 Million JPY | 107.32% |
| 2019 | 423 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 223.62 Million JPY | 26.74% |
| 2023 Q2 | 184.84 Million JPY | 309.62% |
| 2023 Q1 | 45.12 Million JPY | -90.04% |
| 2023 Q4 | 176.44 Million JPY | -72.12% |
| 2023 Q3 | 632.96 Million JPY | 242.43% |
| 2023 FY | 1.03 Billion JPY | -31.87% |
| 2022 Q3 | - JPY | -100.0% |
| 2022 FY | 1.52 Billion JPY | 49.74% |
| 2022 Q4 | 452.86 Million JPY | 0.0% |
| 2022 Q2 | 376.98 Million JPY | 0.0% |
| 2021 FY | 1.01 Billion JPY | 16.18% |
| 2020 FY | 876.97 Million JPY | 107.32% |
| 2019 FY | 423 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 44.752% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -1194.278% |
| GNI Group Ltd. | 22.43 Billion JPY | 95.366% |
| Linical Co., Ltd. | 3.77 Billion JPY | 72.491% |
| Trans Genic Inc. | 2.24 Billion JPY | 53.79% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -957.875% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 58.129% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 19.59% |
| AnGes, Inc. | -3.06 Billion JPY | 133.908% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 684.85% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 89.245% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -100.927% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -836.752% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 28.348% |
| CanBas Co., Ltd. | -984 Million JPY | 205.628% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -165.353% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 37.241% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -160.762% |
| PeptiDream Inc. | 17.21 Billion JPY | 93.964% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -3296.122% |
| Ribomic Inc. | -10.5 Million JPY | 9997.001% |
| SanBio Company Limited | -14.5 Million JPY | 7266.182% |
| Healios K.K. | 108 Million JPY | -862.392% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 304904.399% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 1860.294% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 68842.262% |
| StemRIM | -44.34 Million JPY | 2443.645% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 67.366% |
| FunPep Company Limited | -680.28 Million JPY | 252.786% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -1400.914% |
| Stella Pharma Corporation | 217.29 Million JPY | -378.321% |
| TMS Co., Ltd. | -6.95 Million JPY | 15055.151% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -230.423% |
| Cuorips Inc. | 9.63 Million JPY | -10692.057% |
| K Pharma,Inc. | 910 Million JPY | -14.218% |
| Takara Bio Inc. | 25.45 Billion JPY | 95.917% |
| ReproCELL Incorporated | 1.1 Billion JPY | 5.915% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 13.027% |
| StemCell Institute Inc. | 1.57 Billion JPY | 34.044% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 37.641% |
| CellSeed Inc. | 107.15 Million JPY | -869.981% |